What is the Return on Assets (ROA) of MorphoSys this year?
The Return on Assets (ROA) of MorphoSys is -0.09 undefined this year.
MorphoSys ROA 2024
MorphoSys ROA
-0.09
MorphoSys Dividend yield
Ticker
MOR.DE
ISIN
DE0006632003
WKN
663200
In 2024, MorphoSys's return on assets (ROA) was -0.09, a 48.58% increase from the -0.06 ROA in the previous year.
MorphoSys Aktienanalyse
What does MorphoSys do?
MorphoSys AG is a biotech company based in Planegg near Munich, Germany, founded in 1992. The company specializes in the discovery and development of therapeutic antibodies and operates worldwide. MorphoSys ist eines der beliebtesten Unternehmen auf Eulerpool.com.ROA Details
Understanding MorphoSys's Return on Assets (ROA)
MorphoSys's Return on Assets (ROA) is a key performance indicator that measures the company's profitability in relation to its total assets. It is calculated by dividing the net income by the total assets. A higher ROA indicates efficient asset utilization to generate profits, reflecting managerial effectiveness and financial health.
Year-to-Year Comparison
Comparing MorphoSys's ROA year-over-year provides insights into the company’s operational efficiency and asset utilization trends. An increasing ROA demonstrates enhanced asset efficiency and profitability, while a declining ROA can indicate operational or financial challenges.
Impact on Investments
Investors consider MorphoSys's ROA as a crucial metric to evaluate the company’s profitability and efficiency. A higher ROA signifies that the company is effectively utilizing its assets to generate profits, making it a potentially attractive investment.
Interpreting ROA Fluctuations
Variations in MorphoSys’s ROA can be attributed to changes in net income, asset purchases, or operational efficiencies. Analyzing these fluctuations assists in assessing the company's financial performance, management efficiency, and strategic financial positioning.
Frequently Asked Questions about MorphoSys Stock
What was the ROA of MorphoSys compared to the previous year?
The ROA of MorphoSys has increased by 48.58% compared to the previous year.
What consequences do high ROA have for investors of MorphoSys?
A high ROA is advantageous for investors of MorphoSys, as it indicates that the company efficiently utilizes its assets and generates good profits.
What are the consequences of low ROA for investors in MorphoSys?
A low ROA can be unfavorable for investors of MorphoSys as it indicates that the company is inefficiently utilizing its assets and may potentially achieve lower profits.
How does an increase in the ROA of MorphoSys affect the company?
An increase in ROA of MorphoSys can be an indicator of improved efficiency in asset utilization and higher profitability.
How does a reduction in ROA of MorphoSys impact the company?
A reduction in the ROA of MorphoSys can be an indicator of lower asset efficiency and profitability.
What are some factors that can influence the ROA of MorphoSys?
Some factors that can influence the ROA of MorphoSys include revenue, operating costs, asset structure, and industry average.
Why is the ROA of MorphoSys important for investors?
The ROA of MorphoSys is important for investors as it is an indicator of the company's profitability and efficiency in utilizing assets. It provides investors with information on how well the company utilizes its resources to generate profits.
What strategic measures can MorphoSys take to improve ROA?
To improve ROA, MorphoSys can take measures such as cost savings, revenue growth, optimizing asset structure, and diversifying its business activities. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic measures to improve ROA.
How much dividend does MorphoSys pay?
Over the past 12 months, MorphoSys paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, MorphoSys is expected to pay a dividend of 0 EUR.
What is the dividend yield of MorphoSys?
The current dividend yield of MorphoSys is .
When does MorphoSys pay dividends?
MorphoSys pays a quarterly dividend. This is distributed in the months of .
How secure is the dividend of MorphoSys?
MorphoSys paid dividends every year for the past 0 years.
What is the dividend of MorphoSys?
For the upcoming 12 months, dividends amounting to 0 EUR are expected. This corresponds to a dividend yield of 0 %.
In which sector is MorphoSys located?
MorphoSys is assigned to the 'Health' sector.
Wann musste ich die Aktien von MorphoSys kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of MorphoSys from 4/30/2024 amounting to 0 EUR, you needed to have the stock in your portfolio before the ex-date on 4/30/2024.
When did MorphoSys pay the last dividend?
The last dividend was paid out on 4/30/2024.
What was the dividend of MorphoSys in the year 2023?
In the year 2023, MorphoSys distributed 0 EUR as dividends.
In which currency does MorphoSys pay out the dividend?
The dividends of MorphoSys are distributed in EUR.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The MorphoSys stock can be added to a savings plan with the following providers: Trade Republic, Scalable Capital and Consorsbank
Andere Kennzahlen von MorphoSys
Our stock analysis for MorphoSys Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of MorphoSys Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
